Covid rises in Spain: cases soar while hospitalizations remain contained

The estimated incidence rose from 25.6 to 85 cases per 100,000 inhabitants in two weeks while hospitalization remains at low levels.

Add DEMÓCRATA to Google

Ask FREN

Published

Last updated

3 minutes

Most read

Elecciones 29N · Encuestas

La media de las encuestas

Media a 22 de noviembre de 2026 · 20 institutos

  • PP31,0 %
  • PSOE28,3 %
  • Vox18,7 %
  • Frente Amplio6,0 %
  • ERC2,6 %
01020304050ene 2024jul 2024ene 2025jul 2025ene 2026jul 2026

Media del último estudio de cada instituto en 30 días y su evolución semanal desde el 23J. Partidos con al menos un 2 %.

Todas las encuestas

Elecciones generales del 29 de noviembre · Demócrata

The Covid is rising again in Spain, with a particularly marked increase during September. The latest national report available from the Acute Respiratory Infection Surveillance System (SiVIRA), corresponding to the week of September 14 to 20, places the estimated incidence in Primary Care at 85 cases per 100,000 inhabitants, compared to 25.6 a week earlier.

The increase is also reflected in the tests conducted on patients with respiratory symptoms. The positivity of SARS-CoV-2 rose from 16.7% to 25.8% in one week. The coronavirus is thus the respiratory virus with the highest circulation among the analyzed samples, ahead of the flu, whose indicator was at 22.9 cases per 100,000 inhabitants.

The available data, however, do not show an equivalent increase in severity. The estimated rate of hospitalization due to Covid was at 0.8 cases per 100,000 inhabitants in week 38, compared to 1.2 in the previous week. The total of acute respiratory infections had also not reached the national epidemic threshold.

The increase started before September

The rise is not concentrated in a single week. In the week from August 31 to September 6, the positivity of SARS-CoV-2 was lower than that recorded later. A week later, between September 7 and 13, the rate of Covid syndrome in Primary Care had already increased to 11.3 cases per 100,000 inhabitants, compared to 8 from the previous week.

In that same week 37, the indicator that combines the incidence of respiratory infections with the positivity of the coronavirus estimated an incidence of 25.6 cases per 100,000 inhabitants. In the following week, that same indicator reached 85 cases.

The territorial behavior is also not uniform. In the Comunitat Valenciana, the data published by the regional health showed an increase in the incidence of Covid from 52 to 117 cases per 100,000 inhabitants in one week. The increase led to the advancement of the vaccination campaign for the groups considered priority.

In Murcia, diagnoses increased by 70% in one week according to the surveillance data cited by the regional health. In Galicia, an increase in consultations and admissions has also been observed, especially in the health area of Vigo, although health officials and consulted experts have pointed out that the increase occurs from previously reduced levels.

Andalusia, for its part, has detected an increase in cases both in Primary Care and in hospitals. The Board has classified it as mild and maintains surveillance because the levels of incidence continue to be low. The Andalusian Minister of Health, Antonio Sanz, has pointed out that it is still not possible to talk about the beginning of an epidemic wave.

XFG is the variant that circulates the most

The increase in cases is occurring with XFG as the main identified variant. The genomic characterization carried out by the National Center for Microbiology shows that this variant represents 61.95% of the characterized viruses in the sentinel samples from Primary Care since the beginning of the season until week 34.

The second identified variant is BA.3.2, although with a much lower proportion. The Ministry of Health indicates in its recommendations for the 2026-2027 season that XFG is the preferred option for the update of vaccines and that these vaccines are also expected to provide protection against BA.3.2.

The available data do not point to the emergence of a variant that is causing an extraordinary increase in severity. The Health documentation itself reminds that prior immunity, both from vaccination and from previous infections, is associated with lower clinical severity and a lower risk of complications.

Vaccination begins while circulation increases

The upturn coincides with the start of the vaccination campaigns against Covid and flu in much of Spain. The Ministry of Health recommends this season the Covid vaccine mainly for people aged 70 or older, residents in nursing homes and other closed institutions, people with certain risk conditions, and pregnant women.

The recommendation also extends to certain health and social health professionals and to cohabitants or caregivers of people belonging to risk groups, who can access vaccination as a measure of individual protection.

The new vaccines available for the season incorporate the update against XFG. Health includes among the authorized presentations mRNA vaccines and recombinant protein vaccines, with formulations adapted to the variants currently circulating.

The autonomous communities are applying different calendars. Some began immunization during September, while others have scheduled it for the end of this month or during October. Galicia started the campaign on September 28 in residences and centers for people with disabilities, while Andalusia has set October 1 as the start date for its seasonal campaign.

The current scenario is, therefore, different from that of the early stages of the pandemic. The main indicator that is growing is the circulation of the virus, not the severity of the cases. Monitoring in the coming weeks will allow us to verify whether the increase continues, stabilizes, or reaches a maximum before entering the months of higher circulation of other respiratory viruses.

More key points, information and questions with FREN

AI-GENERATED CONTENT

What are the parliamentary procedures necessary to approve new national vaccination campaigns in Spain?

In Spain, national vaccination campaigns are supported by a prior legal and competency framework, and Parliament intervenes differently depending on whether it concerns ordinary decisions (within the current regulations) or more significant regulatory and budgetary changes.

1. Basic legal framework and distribution of competencies

According to Law 33/2011, General Public Health Law (BOE), preventive actions through vaccinations are part of public health policies. This law establishes that:

  • There must be a basic and common public health service portfolio that includes a single vaccination schedule for the entire country.
  • The Interterritorial Council of the National Health System (CISNS), where the Ministry of Health and the autonomous communities are represented, agrees on:
    • The single vaccination schedule in Spain.
    • Common preventive actions and their periodic evaluation.

Additionally, Royal Decree 1030/2006 and its numerous modification orders (for example, Order SND/454/2025 or Order SND/606/2024) regulate the common service portfolio of the SNS, which integrates vaccination services (schedule, age groups, risk groups, etc.). These regulations are approved by the Government and developed through ministerial orders.

2. Campaigns supported by current regulations

When it comes to launching or intensifying campaigns that fit within the existing schedule and portfolio (for example, annual flu campaigns or boosters of an already included vaccine), the core decisions are executive and technical, not legislative:

  • The Ministry of Health proposes changes to the schedule (frequencies, target groups, etc.) in the Vaccination Program and Registry Panel and in the CISNS.
  • The CISNS approves common recommendations and the communities implement them, organizing the campaign within their health services.
  • The specifics are often channeled via ministerial orders and administrative agreements, or through updates to the annexes of Royal Decree 1030/2006.

In these cases, Parliament does not approve a specific "campaign," but it does:

  • Control vaccination policy through questions, interpellations, motions, and appearances of the minister or senior officials in Plenary or in the Health Commission.
  • Influence the financial capacity of campaigns by approving the General State Budgets (PGE), which include credits for vaccine purchase and public health programs.

That is, if the campaign fits within the already approved legal and budgetary framework, the parliamentary procedure is fundamentally one of political control, not specific approval.

3. Campaigns requiring regulatory changes or new coverages

When a new campaign involves modifying rights, obligations, or basic services (for example, making a vaccine mandatory, creating a new structural vaccination program, or introducing a high-impact service in the basic portfolio), formal parliamentary procedures may be necessary:

  • Ordinary laws:
    • The Government can submit a bill that reforms Law 33/2011 or other health regulations to redefine the vaccination framework (mandates, infractions, etc.).
    • A private member's bill may also arise from one or more parliamentary groups.
    • In both cases, the ordinary procedure is followed: consideration in Plenary, processing in the Health Commission (panel, amendments, report), and new debate and vote in Plenary; then it goes to the Senate and, if applicable, returns to the Congress.
  • Royal decree-laws:
    • In situations of extraordinary and urgent need (e.g., a pandemic), the Government can approve a royal decree-law with rapid vaccination and financing measures.
    • The Congress must ratify or repeal it within a maximum of 30 days, and may also agree to process it as a bill to introduce amendments.
  • General State Budget Laws:
    • If the new campaign requires a significant and stable increase in spending, the Government can include the allocations in the PGE draft.
    • The Congress and Senate debate and amend the budget draft; final approval enables the necessary credits for vaccine purchase and campaign organization.

4. Coordination with autonomous communities

Although the decision to launch a "national campaign" is articulated through state regulations and agreements in the CISNS, the practical execution depends on the autonomous communities, which have the competence to organize health services. Law 33/2011 foresees that:

  • The vaccination schedule is unique, but communities can only modify it for epidemiological reasons.
  • In case of pandemics or other health crises, coordination mechanisms are reinforced, especially for mass vaccination actions.

In summary, Parliament does not approve vaccination campaigns one by one, but it defines the legal, financial, and political framework that makes them possible, through health laws, royal decree-laws in emergencies, and especially the approval and control of the budget and Government action.

Could you detail the specific role of the Interterritorial Council in approving the common vaccination schedule? What parliamentary control instruments have been recently used to oversee the Government's vaccination strategy? How is the possible mandatory nature of certain vaccines legally articulated in Spain and what margin do the autonomous communities have?

What competencies does an autonomous Health Minister have and what role do they play in managing vaccination campaigns?

An autonomous Health Minister is the highest political authority of health in an autonomous community. They perform functions of direction, planning, and coordination of the health system in their territory, within the basic state framework. In vaccination campaigns, they are at the apex of decision-making and coordination with the Ministry of Health and the autonomous health service, although day-to-day execution falls to technical teams and the care network.

General competencies of a Health Minister

Although the specific organization may vary by community, the Health Minister usually has the following competencies:

  • Political direction of the autonomous health system: sets the health priorities of the autonomous government, defines strategic lines (e.g., strengthening primary care, waiting lists, mental health, public health), and directs the ministry and health service (or equivalent entity).
  • Health planning and regulation: promotes health plans, specific strategies (chronic diseases, cancer, public health, vaccination, etc.), and resource distribution in the territory (hospitals, health centers, public health devices).
  • Normative competencies within the state framework: proposes to the autonomous Government Council the approval of decrees, orders, and other regulatory instruments in health matters (e.g., complementary service portfolios, internal system organization, public health regulations within their competencies).
  • Budget management and proposal: designs and defends the community's health budget before the Ministry of Finance and the autonomous parliament, decides internal resource allocation and spending prioritization (hospitals, primary care, public health, pharmacy, investments, etc.).
  • Senior management of the autonomous health service: appoints or proposes appointments of top health service officials, area managers, general directors, and other key positions, and sets management and quality objectives.
  • Coordination and institutional representation: represents the community in interterritorial coordination bodies, especially within the National Health System, and liaises with other ministries (education, social services, interior, etc.) when health policies require it.
  • Crisis management and public health: assumes political direction in health emergencies (epidemic outbreaks, environmental crises impacting health, etc.), making decisions on prevention measures, restrictions, and additional resources.
  • Public communication on health matters: is one of the main voices of the autonomous government in health; explains, justifies, and defends decisions before citizens and the media.

Role in vaccination campaigns

In vaccination campaigns, the Health Minister's role is articulated in several phases, combining political decisions, technical coordination, and communication:

  • Strategic planning: participates in defining campaign objectives in their territory (coverage targets, priority groups, schedule), usually based on state recommendations and the community's public health technical bodies.
  • Coordination with the Ministry of Health: participates, directly or through senior officials, in the Interterritorial Council of the National Health System and its technical commissions. There, common vaccination schedules, group prioritization, and general criteria for major campaigns (e.g., flu, COVID-19, meningitis) are agreed upon.
  • Decision on autonomous implementation: adapts state strategies to the autonomous reality: defines whether to reinforce certain devices (mobile teams, vaccination in schools, extended hours), how to stagger age or risk groups, and what additional resources to mobilize.
  • Resource allocation: decides, with their team, the staffing (temporary hires, overtime, reinforcements in primary care and public health), logistics (storage, dose distribution, mass vaccination points), and budget needed for the campaign.
  • Relationship with the health service and care devices: gives general directives to the autonomous health service, which organizes the concrete operation in hospitals, health centers, and other points. The minister supervises deployment at a high level, reviews monitoring reports, and can order adjustments.
  • Monitoring and evaluation: periodically receives data on coverage by age group, incidences, vaccine acceptability, and reported adverse effects. With this information, they can decide to intensify campaigns in certain groups, open new vaccination points, or modify messages.
  • Public communication and leadership: is usually the visible face of the campaign at the autonomous level. Presents the campaign in press conferences, encourages vaccination, clarifies doubts about safety and effectiveness, and can act alongside reference professionals (service chiefs, public health experts) to reinforce message credibility.
  • Management of shortages or changes in criteria: if there are supply problems, changes in scientific indications, or relevant adverse effects, the minister decides, in coordination with the Ministry and technical teams, adjustments in prioritization, possible temporary pauses, and how to communicate this to the population.

In summary, the Health Minister does not administer vaccines nor designs technical protocols alone, but politically and strategically leads the campaign in their community, coordinates with the State, and deploys the human, material, and communication resources necessary to achieve the set public health objectives.

Could you explain with concrete examples how a Health Minister and the Ministry coordinate in a state vaccination campaign? What differences can exist between autonomous communities in the practical organization of a vaccination campaign? What role do municipalities and other administrative levels play in supporting autonomous vaccination campaigns?

How many COVID-19 vaccination campaigns have been carried out in Spain since the start of the pandemic?

There is no document from the Ministry of Health that literally states "in Spain, X COVID-19 vaccination campaigns have been carried out." However, based on the official vaccination strategy started in 2020 and the seasonal campaign history published by Health (combined autumn-winter flu-COVID campaigns each year), it is reasonable to speak of at least seven major national campaigns from the start of the pandemic through the 2026-2027 season.

The structure is as follows:

  • 1. Initial 2020-2021 campaign
    It started on December 27, 2020, when the first doses began to be administered in nursing homes and to healthcare personnel, within the Vaccination Strategy agreed upon in the Interterritorial Council and presented by the Government in November 2020 (included, among others, in the note "COVID-19 Vaccination: strategy keys and current recommendations" from Moncloa, 11/21/2024).
    This was the initial massive deployment campaign, with successive phases: nursing homes and social-health personnel, older adults by age groups, essential personnel, and finally the general adult population.
  • 2. Booster campaign 2021-2022
    Once initial schedules were completed in much of the population, booster doses were organized, especially for older adults, people with risk pathologies, and residents in long-term care centers. Although not always presented in the media as a distinct "new campaign," in practice it represented a second major vaccination round focused on vulnerable groups.
  • 3. Seasonal autumn-winter 2022-2023 campaign
    From this stage, COVID vaccination became integrated with the seasonal flu campaign, with specific recommendations for autumn booster doses for older adults and risk groups. The Ministry began to refer to a "seasonal" COVID-19 scheme, coordinated with the autonomous communities.
  • 4. Seasonal 2023-2024 campaign
    The annual autumn-winter campaign model continued, combined flu-COVID, with vaccines adapted to the epidemiological situation and aimed at the same priority groups (older adults, pregnant women, people with chronic diseases, healthcare personnel), according to recommendations grouped by Health in its seasonal campaign history.
  • 5. Seasonal 2024-2025 campaign
    Formally presented by the Minister of Health as a seasonal vaccination campaign against flu and COVID-19 for autumn-winter 2024-2025 (Moncloa note 10/07/2024).
    The goal was set to reach 75% coverage in older adults and healthcare personnel and 60% in pregnant women and people with risk conditions, with strong emphasis on simultaneous flu-COVID vaccination.
  • 6. Seasonal 2025-2026 campaign
    Health published specific recommendations for the 2025-2026 season: one seasonal dose of COVID vaccine, regardless of the number of previous doses or infections, respecting a minimum interval since the last dose (documents such as "COVID-19 Vaccination Recommendations for the 2025-2026 season" and associated Q&A).
    The campaign is again integrated with flu, starting in late September and October, focused on older adults, immunocompromised people, and other vulnerable groups.
  • 7. Seasonal 2026-2027 campaign
    For 2026-2027, the joint autumn-winter flu-COVID campaign scheme is maintained, with recommendations published by Health and reflected in specialized press, again emphasizing priority for nursing homes, people over 60, and high-risk groups. At the European level, the European Medicines Agency plans to adapt vaccine composition to recent SARS-CoV-2 variants precisely for this campaign.

In summary, even without a single official "counter," the available information allows identifying: one major initial campaign in 2020-2021, a booster campaign 2021-2022, and since then, five annual seasonal campaigns (2022-2023, 2023-2024, 2024-2025, 2025-2026, and 2026-2027).
That is, at least seven major COVID-19 vaccination campaigns in Spain, initially organized as emergency mass vaccination and later as a consolidated seasonal vaccination coordinated with the flu campaign.

Play

Test your knowledge with FREN!

How much do you know about this topic? Answer the following 3 questions.

Which indicator has experienced the greatest increase in Spain during September 2026 in relation to Covid?

Question 1 of 3

What percentage of sentinel Primary Care samples corresponded to the XFG variant of SARS-CoV-2?

Question 2 of 3

To which groups does the Ministry of Health recommend Covid vaccination in the current season?

Question 3 of 3